Journal
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
Volume 144, Issue 1, Pages 33-38Publisher
MOSBY-ELSEVIER
DOI: 10.1016/j.jtcvs.2012.05.060
Keywords
-
Funding
- Toshiba
- Oncimmune
- Metabolomx
- Astellas Canada
- Axela/Exceed
- Eli Lilly
- National Institute for Health Research [09/61/01, 07/82/01] Funding Source: researchfish
Ask authors/readers for more resources
Objective: Lung cancer is the leading cause of cancer death in North America. Low-dose computed tomography screening can reduce lung cancer-specific mortality by 20%. Method: The American Association for Thoracic Surgery created a multispecialty task force to create screening guidelines for groups at high risk of developing lung cancer and survivors of previous lung cancer. Results: The American Association for Thoracic Surgery guidelines call for annual lung cancer screening with low-dose computed tomography screening for North Americans from age 55 to 79 years with a 30 pack-year history of smoking. Long-term lung cancer survivors should have annual low-dose computed tomography to detect second primary lung cancer until the age of 79 years. Annual low-dose computed tomography lung cancer screening should be offered starting at age 50 years with a 20 pack-year history if there is an additional cumulative risk of developing lung cancer of 5% or greater over the following 5 years. Lung cancer screening requires participation by a subspecialty-qualified team. The American Association for Thoracic Surgery will continue engagement with other specialty societies to refine future screening guidelines. Conclusions: The American Association for Thoracic Surgery provides specific guidelines for lung cancer screening in North America. (J Thorac Cardiovasc Surg 2012;144:33-8)
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available